Cargando…

New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3

PURPOSE: The aim of this study was to explore a new model of clinical decision-making to predict the occurrence of clinically significant prostate cancer (csPCa). PATIENTS AND METHODS: The demographic and clinical characteristics of 152 patients were recorded. Prostate-specific antigen (PSA), PSA de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chen, Qiu, Feng, Jin, Di, Wei, Xuedong, Chen, Zongxin, Wang, Ximing, Zhao, Xiaojun, Guo, Linchuan, Pu, Jinxian, Hou, Jianquan, Huang, Yuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289138/ https://www.ncbi.nlm.nih.gov/pubmed/35860546 http://dx.doi.org/10.3389/fonc.2022.908956

Ejemplares similares

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022)

A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score
por: Chen, Zongxin, et al.
Publicado: (2023)

Prostate Biopsy in the Case of PIRADS 5—Is Systematic Biopsy Mandatory?
por: Malewski, Wojciech, et al.
Publicado: (2023)

New model of PIRADS and adjusted prostate-specific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study
por: Huang, Chen, et al.
Publicado: (2022)

Performance of multi-parametric magnetic resonance imaging through PIRADS scoring system in biopsy naïve patients with suspicious prostate cancer
por: Nowier, Amr, et al.
Publicado: (2022)

Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA
por: Müller, Stig, et al.
Publicado: (2018)

Predictors of Clinically Significant Prostate Cancer in Patients with PIRADS Categories 3–5 Undergoing Magnetic Resonance Imaging-Ultrasound Fusion Biopsy of the Prostate
por: Szempliński, Stanisław, et al.
Publicado: (2022)

Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system
por: Alqahtani, Saeed, et al.
Publicado: (2020)

Data-driven translational prostate cancer research: from biomarker discovery to clinical decision
por: Lin, Yuxin, et al.
Publicado: (2020)

A Novel Nomogram Combined the Aggregate Index of Systemic Inflammation and PIRADS Score to Predict the Risk of Clinically Significant Prostate Cancer
por: Xie, Wenliang, et al.
Publicado: (2023)

Effectiveness of Bi-Parametric MR/US Fusion Biopsy for Detecting Clinically Significant Prostate Cancer in Prostate Biopsy Naïve Men
por: Kim, Young Joo, et al.
Publicado: (2019)

Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population
por: Zhou, Feng, et al.
Publicado: (2016)

Development and validation of a nomogram for predicting the overall survival of prostate cancer patients: a large population-based cohort study
por: Zhou, Zheng, et al.
Publicado: (2022)

The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions
por: Zattoni, Fabio, et al.
Publicado: (2023)

Small lymphocytic lymphoma of the prostate mimicking a PIRADS 5 lesion that resolved after systemic treatment
por: Wong, Tiffany H., et al.
Publicado: (2021)

Prognostic significance of sarcopenia and systemic inflammation for patients with renal cell carcinoma following nephrectomy
por: Liu, Qiuchen, et al.
Publicado: (2022)

Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies
por: Krüger-Stokke, Brage, et al.
Publicado: (2021)

MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins
por: He, Dong, et al.
Publicado: (2021)

Expression and clinical significance of interleukin-9 in renal tumors
por: Zhang, Zhiyu, et al.
Publicado: (2020)

B7-H3 promoted proliferation of mouse spermatogonial stem cells via the PI3K signaling pathway
por: Wei, Xuedong, et al.
Publicado: (2017)

Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study
por: Velaga, Jyothirmayi, et al.
Publicado: (2023)

Assessing the accuracy of multiparametric MRI to predict clinically significant prostate cancer in biopsy naïve men across racial/ethnic groups
por: Meza, Julio, et al.
Publicado: (2022)

Temporal changes of PIRADS scoring by radiologists and correlation to radical prostatectomy pathological outcomes
por: Hong, Sung Kyu, et al.
Publicado: (2022)

Application of transrectal ultrasound-guided repeat needle biopsy in the diagnosis of prostate cancer in Chinese population: A retrospective study
por: Wang, Yi, et al.
Publicado: (2016)

B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis
por: Zhou, Yunfen, et al.
Publicado: (2020)

Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
por: Carbunaru, Samuel, et al.
Publicado: (2021)

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men
por: Peltier, Alexandre, et al.
Publicado: (2015)

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
por: Zhang, Kai, et al.
Publicado: (2020)

Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey
por: Lin, Yuxin, et al.
Publicado: (2021)

Resection of adult polycystic kidney with retroperitoneal laparoscopic technique assisted by arterial embolization
por: Li, Feng, et al.
Publicado: (2020)

The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer
por: Geng, Xinyu, et al.
Publicado: (2020)

Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy
por: Zhou, Chenchao, et al.
Publicado: (2017)

Outcomes of standard 12-core transrectal ultrasound-guided prostate biopsy in biopsy naive Indian men -single center experience
por: Laddha, Abhishek, et al.
Publicado: (2020)

Robotic-assisted magnetic resonance imaging ultrasound fusion results in higher significant cancer detection compared to cognitive prostate targeting in biopsy naive men
por: Patel, Manish I., et al.
Publicado: (2020)

Prostate health index is useful for prostate cancer detecting in Chinese people
por: Huang, Yuhua, et al.
Publicado: (2019)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

MultiParametric Magnetic Resonance Imaging-Based Nomogram for Predicting Prostate Cancer and Clinically Significant Prostate Cancer in Men Undergoing Repeat Prostate Biopsy
por: Huang, Cong, et al.
Publicado: (2018)

A Single Nucleotide Polymorphism in HPGD Gene Is Associated with Prostate Cancer Risk
por: Qi, Xiaofei, et al.
Publicado: (2017)

The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A propensity score matching analysis
por: Byun, Hye J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jhi859j1tn4r0jd6c52sj8cc6c